Table I.
Data on 4-nitroquinoline 1-oxide (4-NQO)-induced oral and esophageal cancer development in mice.
Treatment groups | Number of mice | Initial body weight (g) | Final body weight (g) | Site | Number of animal affected | Number of dysplasia or tumor mass |
---|---|---|---|---|---|---|
Control | 10 | 23.69 ± 1.902 | 33.63 ± 5.3 | Tongue | 0 | 0 |
Esophagus | 0 | 0 | ||||
4-NQO | ||||||
15 μg/ml | 10 | 22.5 ± 1.211 | 32.23 ± 4.7 | Tongue | 1 | 1 |
Esophagus | 4 | 7 | ||||
30 μg/ml | 10 | 23.53 ± 1.271 | 26.14 ± 3.5 | Tongue | 7 | 14 |
Esophagus | 8 | 19 | ||||
45 μg/ml | 10 | 22.62 ± 1.651 | 23.97 ± 1.5 | Tongue | 9 | 19 |
Esophagus | 8 | 12 |